Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GlyT1 inhibitors for use in the treatment of hematological disorders

GlyT1 inhibitors for use in the treatment of hematological disorders

US Patent 9877963 · Granted Jan 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable subst2024
Isoxazolyl ether derivatives as GABAA α5 PAM2023
Compounds for treating spinal muscular atrophy2023
Phenoxymethyl derivatives2022
Isoxazolyl ether derivatives as GABAA α5 PAM2021
Compounds for treating spinal muscular atrophy2020
Phenoxymethyl derivatives2020
Compounds for treating spinal muscular atrophy2019
Compounds for treating spinal muscular atrophy2019
Substituted imidazo[1,2-α]pyrazines for treating spinal muscular atrophy2018
Pyrrolopyridine or pyrazolopyridine derivatives2018
Compounds for treating spinal muscular atrophy2018